The global Brain Cancer Treatment market was valued at US$2.6 billion in 2022 and is projected to reach US$4.23 billion by 2030, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2022-2027.
The market estimates accounted for short-term impacts of the COVID-19 pandemic as well as medium-term impacts of geopolitical conflicts like the Russia-Ukraine war based on a market impact assessment conducted by 24Market Reports in 2022.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Treatment. This report contains market size and forecasts of Brain Cancer Treatment in global, including the following market information:
- Global Brain Cancer Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Chemotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Brain Cancer Treatment include Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer,Inc, Y-mAbs Therapeutics,Inc, Merck & Co.Inc, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb and Amgen Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Brain Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Cancer Treatment Market,
by Type, 2018-2023, 2024-2032 ($ millions)
Global Brain Cancer Treatment Market Segment Percentages,
by Type, 2022 (%)
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Others
Global Brain Cancer Treatment Market,
by Application, 2018-2023, 2024-2032 ($ millions)
Global Brain Cancer Treatment Market Segment Percentages,
by Application, 2022 (%)
- Primary Brain Cancer
- Secondary Brain Cancer
Global Brain Cancer Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Brain Cancer Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Brain Cancer Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Brain Cancer Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Pfizer,Inc
- Y-mAbs Therapeutics,Inc
- Merck & Co.Inc
- Johnson & Johnson
- AstraZeneca
- Bristol-Myers Squibb
- Amgen Inc
- GlaxoSmith Kline PLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brain Cancer Treatment, market overview.
Chapter 2: Global Brain Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Brain Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brain Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Brain Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Cancer Treatment Overall Market Size
2.1 Global Brain Cancer Treatment Market Size: 2022 VS 2032
2.2 Global Brain Cancer Treatment Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Cancer Treatment Players in Global Market
3.2 Top Global Brain Cancer Treatment Companies Ranked by Revenue
3.3 Global Brain Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Brain Cancer Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Brain Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Brain Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Brain Cancer Treatment Market Size Markets, 2022 & 2032
4.1.2 Chemotherapy
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.1.5 Others
4.2 By Type - Global Brain Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Brain Cancer Treatment Revenue, 2018-2023
4.2.2 By Type - Global Brain Cancer Treatment Revenue, 2024-2032
4.2.3 By Type - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brain Cancer Treatment Market Size, 2022 & 2032
5.1.2 Primary Brain Cancer
5.1.3 Secondary Brain Cancer
5.2 By Application - Global Brain Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Brain Cancer Treatment Revenue, 2018-2023
5.2.2 By Application - Global Brain Cancer Treatment Revenue, 2024-2032
5.2.3 By Application - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Brain Cancer Treatment Market Size, 2022 & 2032
6.2 By Region - Global Brain Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Brain Cancer Treatment Revenue, 2018-2023
6.2.2 By Region - Global Brain Cancer Treatment Revenue, 2024-2032
6.2.3 By Region - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Brain Cancer Treatment Revenue, 2018-2032
6.3.2 US Brain Cancer Treatment Market Size, 2018-2032
6.3.3 Canada Brain Cancer Treatment Market Size, 2018-2032
6.3.4 Mexico Brain Cancer Treatment Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Brain Cancer Treatment Revenue, 2018-2032
6.4.2 Germany Brain Cancer Treatment Market Size, 2018-2032
6.4.3 France Brain Cancer Treatment Market Size, 2018-2032
6.4.4 U.K. Brain Cancer Treatment Market Size, 2018-2032
6.4.5 Italy Brain Cancer Treatment Market Size, 2018-2032
6.4.6 Russia Brain Cancer Treatment Market Size, 2018-2032
6.4.7 Nordic Countries Brain Cancer Treatment Market Size, 2018-2032
6.4.8 Benelux Brain Cancer Treatment Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Brain Cancer Treatment Revenue, 2018-2032
6.5.2 China Brain Cancer Treatment Market Size, 2018-2032
6.5.3 Japan Brain Cancer Treatment Market Size, 2018-2032
6.5.4 South Korea Brain Cancer Treatment Market Size, 2018-2032
6.5.5 Southeast Asia Brain Cancer Treatment Market Size, 2018-2032
6.5.6 India Brain Cancer Treatment Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Brain Cancer Treatment Revenue, 2018-2032
6.6.2 Brazil Brain Cancer Treatment Market Size, 2018-2032
6.6.3 Argentina Brain Cancer Treatment Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Brain Cancer Treatment Revenue, 2018-2032
6.7.2 Turkey Brain Cancer Treatment Market Size, 2018-2032
6.7.3 Israel Brain Cancer Treatment Market Size, 2018-2032
6.7.4 Saudi Arabia Brain Cancer Treatment Market Size, 2018-2032
6.7.5 UAE Brain Cancer Treatment Market Size, 2018-2032
7 Brain Cancer Treatment Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Brain Cancer Treatment Major Product Offerings
7.1.4 Novartis AG Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd
7.2.1 F. Hoffmann-La Roche Ltd Company Summary
7.2.2 F. Hoffmann-La Roche Ltd Business Overview
7.2.3 F. Hoffmann-La Roche Ltd Brain Cancer Treatment Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.3 Pfizer,Inc
7.3.1 Pfizer,Inc Company Summary
7.3.2 Pfizer,Inc Business Overview
7.3.3 Pfizer,Inc Brain Cancer Treatment Major Product Offerings
7.3.4 Pfizer,Inc Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.3.5 Pfizer,Inc Key News & Latest Developments
7.4 Y-mAbs Therapeutics,Inc
7.4.1 Y-mAbs Therapeutics,Inc Company Summary
7.4.2 Y-mAbs Therapeutics,Inc Business Overview
7.4.3 Y-mAbs Therapeutics,Inc Brain Cancer Treatment Major Product Offerings
7.4.4 Y-mAbs Therapeutics,Inc Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.4.5 Y-mAbs Therapeutics,Inc Key News & Latest Developments
7.5 Merck & Co.Inc
7.5.1 Merck & Co.Inc Company Summary
7.5.2 Merck & Co.Inc Business Overview
7.5.3 Merck & Co.Inc Brain Cancer Treatment Major Product Offerings
7.5.4 Merck & Co.Inc Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.5.5 Merck & Co.Inc Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Brain Cancer Treatment Major Product Offerings
7.6.4 Johnson & Johnson Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Brain Cancer Treatment Major Product Offerings
7.7.4 AstraZeneca Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Brain Cancer Treatment Major Product Offerings
7.8.4 Bristol-Myers Squibb Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Amgen Inc
7.9.1 Amgen Inc Company Summary
7.9.2 Amgen Inc Business Overview
7.9.3 Amgen Inc Brain Cancer Treatment Major Product Offerings
7.9.4 Amgen Inc Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.9.5 Amgen Inc Key News & Latest Developments
7.10 GlaxoSmith Kline PLC
7.10.1 GlaxoSmith Kline PLC Company Summary
7.10.2 GlaxoSmith Kline PLC Business Overview
7.10.3 GlaxoSmith Kline PLC Brain Cancer Treatment Major Product Offerings
7.10.4 GlaxoSmith Kline PLC Brain Cancer Treatment Revenue in Global Market (2018-2023)
7.10.5 GlaxoSmith Kline PLC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Brain Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Brain Cancer Treatment Market Drivers in Global Market
Table 3. Brain Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Brain Cancer Treatment in Global Market
Table 5. Top Brain Cancer Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Brain Cancer Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Brain Cancer Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Brain Cancer Treatment Product Type
Table 9. List of Global Tier 1 Brain Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Brain Cancer Treatment Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Brain Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Brain Cancer Treatment Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Brain Cancer Treatment Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Brain Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Brain Cancer Treatment Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Brain Cancer Treatment Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Brain Cancer Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Brain Cancer Treatment Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Brain Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Brain Cancer Treatment Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Brain Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Brain Cancer Treatment Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Brain Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Brain Cancer Treatment Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Brain Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Brain Cancer Treatment Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Brain Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Brain Cancer Treatment Revenue, (US$, Mn), 2024-2032
Table 30. Novartis AG Company Summary
Table 31. Novartis AG Brain Cancer Treatment Product Offerings
Table 32. Novartis AG Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Ltd Company Summary
Table 35. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Product Offerings
Table 36. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 38. Pfizer,Inc Company Summary
Table 39. Pfizer,Inc Brain Cancer Treatment Product Offerings
Table 40. Pfizer,Inc Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer,Inc Key News & Latest Developments
Table 42. Y-mAbs Therapeutics,Inc Company Summary
Table 43. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Product Offerings
Table 44. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Y-mAbs Therapeutics,Inc Key News & Latest Developments
Table 46. Merck & Co.Inc Company Summary
Table 47. Merck & Co.Inc Brain Cancer Treatment Product Offerings
Table 48. Merck & Co.Inc Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Merck & Co.Inc Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Brain Cancer Treatment Product Offerings
Table 52. Johnson & Johnson Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Brain Cancer Treatment Product Offerings
Table 56. AstraZeneca Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Brain Cancer Treatment Product Offerings
Table 60. Bristol-Myers Squibb Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Amgen Inc Company Summary
Table 63. Amgen Inc Brain Cancer Treatment Product Offerings
Table 64. Amgen Inc Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Amgen Inc Key News & Latest Developments
Table 66. GlaxoSmith Kline PLC Company Summary
Table 67. GlaxoSmith Kline PLC Brain Cancer Treatment Product Offerings
Table 68. GlaxoSmith Kline PLC Brain Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. GlaxoSmith Kline PLC Key News & Latest Developments
List of Figures
Figure 1. Brain Cancer Treatment Segment by Type in 2022
Figure 2. Brain Cancer Treatment Segment by Application in 2022
Figure 3. Global Brain Cancer Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brain Cancer Treatment Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Brain Cancer Treatment Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Cancer Treatment Revenue in 2022
Figure 8. By Type - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 9. By Application - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 10. By Type - Global Brain Cancer Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 12. By Application - Global Brain Cancer Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 14. By Region - Global Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 15. By Country - North America Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 16. US Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 20. Germany Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 21. France Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 28. China Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 32. India Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 34. Brazil Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Brain Cancer Treatment Revenue Market Share, 2018-2032
Figure 37. Turkey Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Brain Cancer Treatment Revenue, (US$, Mn), 2018-2032
Figure 41. Novartis AG Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer,Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck & Co.Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amgen Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GlaxoSmith Kline PLC Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
